Skip to main content
. 2021 Jan 15;12(1):270–280. doi: 10.1080/21505594.2020.1870080

Table 2.

Final model of the stepwise regression analysis for pre-therapy factors associated with pre-therapy eNAMPT levels in CHC patients

Variants Estimated β 95% CI β T values p Values
Intercept 11.0591 7.6116 ~ 14.5067 6.29 9.20X10−10
BMI (kg/m2) −0.1252 −0.2282~-0.02222 −2.38 0.017718
HCV RNA (Log10 IU/ml) −0.4434 −0.8026~-0.0842 −2.42 0.0160349
HOMA-IR 0.15655 0.0723 ~ 0.2408 3.64 0.0003074

CHC: chronic hepatitis C virus infection; eNAMPT: extracellular nicotinamide phosphoribosyltransferase; CI: confidence interval; BMI: body mass index; Log: logarithmic; HOMA-IR: homeostasis model assessment-estimated insulin resistance.